Scienture Holdings, Inc. Common StockSCNX
About: Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Employees: 19
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
90% more capital invested
Capital invested by funds: $298K [Q3] → $567K (+$269K) [Q4]
50% more funds holding
Funds holding: 6 [Q3] → 9 (+3) [Q4]
0.61% more ownership
Funds ownership: 0.46% [Q3] → 1.07% (+0.61%) [Q4]
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for SCNX.
Financial journalist opinion
Based on 4 articles about SCNX published over the past 30 days









